🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Muhammad Umair Mushtaq

Health Innovations (United States)

ORCID: 0000-0001-8122-0563

Also affiliated with The University of Kansas Cancer Center, Health Care Foundation of Greater Kansas City, University of Kansas Medical Center

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Precision therapy with anaplastic lymphoma kinase inhibitor ceritinib in ALK-rearranged anaplastic large cell lymphoma”.

Precision therapy with anaplastic lymphoma kinase inhibitor ceritinib in ALK-rearranged anaplastic large cell lymphoma

ESMO Open(2021)10.1016/j.esmoop.2021.100172

N/A

0.385DataRank · unranked

12 citations

Sudhakiranmayi Kuravi, Siddhartha Ganguly, Danny R. Welch, Carolyn J. Vivian, Muhammad Umair Mushtaq +11 more

Prospective longitudinal study of kinetics of humoral response to one, two, or three doses of SARS-CoV-2 vaccine in hematopoietic cell transplant recipients

Bone Marrow Transplantation(2022)10.1038/s41409-022-01653-2

N/A

0DataRank · unranked

8 citations

Cory Bivona, Ben Liu, Maggie Nelson, Grace Martin, Muhammad Umair Mushtaq +14 more

The Glass Wall: Gendered Authorship Disparities in CD 19 and BCMA CAR-T Clinical Trials for Lymphoma and Myeloma

Clinical Lymphoma Myeloma & Leukemia(2024)10.1016/j.clml.2024.05.022

N/A

0DataRank · unranked

3 citations

William Wesson, Emerson Logan, Carine Tabak, Muhammad Umair Mushtaq, Tara L. Lin +7 more